Real-life treatment of cholinergic urticaria with omalizumab

被引：23

作者：

Altrichter, Sabine ^{[1
]}

Chuamanochan, Mati ^{[1
,2
]}

Knoth, Henriette ^{[1
]}

Asady, Aida ^{[1
]}

Ohanyan, Tatevik ^{[1
]}

Metz, Martin ^{[1
]}

Maurer, Marcus ^{[1
]}

机构：

[1] Charit Univ Med Berlin, Dept Dermatol & Allergy, Berlin, Germany

[2] Chiang Mai Univ, Div Dermatol, Dept Internal Med, Fac Med, Chiang Mai, Thailand

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2019年 / 143卷 / 02期

关键词：

INDUCIBLE URTICARIA; COLD; IGE;

D O I：

10.1016/j.jaci.2018.08.050

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：788 / +

页数：19

共 15 条

[1] Development of a standardized pulse-controlled ergometry test for diagnosing and investigating cholinergic urticaria [J].

Altrichter, Sabine ;

Salow, Julia ;

Ardelean, Elena ;

Church, Martin K. ;

Werner, Andreas ;

Maurer, Marcus .

JOURNAL OF DERMATOLOGICAL SCIENCE, 2014, 75 (02) :88-93

[2] Cholinergic urticaria patients of different age groups have distinct features [J].

Asady, A. ;

Ruft, J. ;

Ellrich, A. ;

Hawro, T. ;

Maurer, M. ;

Altrichter, S. .

CLINICAL AND EXPERIMENTAL ALLERGY, 2017, 47 (12) :1609-1614

[3] Increased IgE levels are linked to faster relapse in patients with omalizumab-discontinued chronic spontaneous urticaria [J].

Ertas, Ragip ;

Ozyurt, Kemal ;

Ozlu, Emin ;

Ulas, Yilmaz ;

Avci, Atil ;

Atasoy, Mustafa ;

Hawro, Tomasz ;

Maurer, Marcus .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 140 (06) :1749-+

[4] Cholinergic urticaria: epidemiology, physiopathology, new categorization, and management [J].

Fukunaga, Atsushi ;

Washio, Ken ;

Hatakeyama, Mayumi ;

Oda, Yoshiko ;

Ogura, Kanako ;

Horikawa, Tatsuya ;

Nishigori, Chikako .

CLINICAL AUTONOMIC RESEARCH, 2018, 28 (01) :103-113

[5] Serum autoreactivity predicts time to response to omalizumab therapy in chronic spontaneous urticaria [J].

Gericke, Janine ;

Metz, Martin ;

Ohanyan, Tatevik ;

Weller, Karsten ;

Altrichter, Sabine ;

Skov, Per Stahl ;

Falkencrone, Sidsel ;

Brand, Janko ;

Kromminga, Arno ;

Hawro, Tomasz ;

Church, Martin K. ;

Maurer, Marcus .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (03) :1059-1061

[6] Effectiveness and safety of omalizumab in chronic spontaneous or inducible urticaria: evaluation of 154 patients [J].

Ghazanfar, M. N. ;

Sand, C. ;

Thomsen, S. F. .

BRITISH JOURNAL OF DERMATOLOGY, 2016, 175 (02) :404-406

[7] Elevated Serum IgE against MGL_1304 in Patients with Atopic Dermatitis and Cholinergic Urticaria [J].

Hiragun, Makiko ;

Hiragun, Takaaki ;

Ishii, Kaori ;

Suzuki, Hidenori ;

Tanaka, Akio ;

Yanase, Yuhki ;

Mihara, Shoji ;

Haruta, Yoshinori ;

Kohno, Nobuoki ;

Hide, Michihiro .

ALLERGOLOGY INTERNATIONAL, 2014, 63 (01) :83-93

[8] An improved Peltier effect-based instrument for critical temperature threshold measurement in cold- and heat-induced urticaria [J].

Magerl, M. ;

Abajian, M. ;

Krause, K. ;

Altrichter, S. ;

Siebenhaar, F. ;

Church, M. K. .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2015, 29 (10) :2043-2045

[9] Omalizumab treatment in patients with chronic inducible urticaria: A systematic review of published evidence [J].

Maurer, Marcus ;

Metz, Martin ;

Brehler, Randolf ;

Hillen, Uwe ;

Jakob, Thilo ;

Mahler, Vera ;

Pfohler, Claudia ;

Staubach, Petra ;

Treudler, Regina ;

Wedi, Bettina ;

Magerl, Markus .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) :638-649

[10] Successful treatment of cholinergic urticaria with anti-immunoglobulin E therapy [J].

Metz, M. ;

Bergmann, P. ;

Zuberbier, T. ;

Maurer, M. .

ALLERGY, 2008, 63 (02) :247-249

← 1 2 →